Bio Green Energy Tech PCL (BKK:BIOTEC)

Bio Green Energy Tech PCL Statistics

Total Valuation

BKK:BIOTEC has a market cap or net worth of THB 671.74 million. The enterprise value is 1.30 billion.

Market Cap	671.74M
Enterprise Value	1.30B

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

BKK:BIOTEC has 3.05 billion shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	3.05B
Shares Outstanding	3.05B
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	45.84%
Owned by Institutions (%)	0.05%
Float	1.06B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.17
PB Ratio	0.66
P/TBV Ratio	1.84
P/FCF Ratio	2.65
P/OCF Ratio	2.32
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.55, with an EV/FCF ratio of 5.15.

EV / Earnings	-11.15
EV / Sales	0.33
EV / EBITDA	13.55
EV / EBIT	n/a
EV / FCF	5.15

Financial Position

The company has a current ratio of 0.38, with a Debt / Equity ratio of 0.63.

Current Ratio	0.38
Quick Ratio	0.20
Debt / Equity	0.63
Debt / EBITDA	6.73
Debt / FCF	2.55
Interest Coverage	0.06

Financial Efficiency

Return on equity (ROE) is -10.51% and return on invested capital (ROIC) is 0.09%.

Return on Equity (ROE)	-10.51%
Return on Assets (ROA)	0.07%
Return on Invested Capital (ROIC)	0.09%
Return on Capital Employed (ROCE)	0.21%
Revenue Per Employee	19.63M
Profits Per Employee	-581,986
Employee Count	201
Asset Turnover	1.50
Inventory Turnover	20.31

Taxes

In the past 12 months, BKK:BIOTEC has paid 9.75 million in taxes.

Income Tax	9.75M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.00% in the last 52 weeks. The beta is 0.12, so BKK:BIOTEC's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	+15.00%
50-Day Moving Average	0.18
200-Day Moving Average	0.21
Relative Strength Index (RSI)	70.60
Average Volume (20 Days)	1,584,226

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BKK:BIOTEC had revenue of THB 3.95 billion and -116.98 million in losses. Loss per share was -0.04.

Revenue	3.95B
Gross Profit	134.16M
Operating Income	2.90M
Pretax Income	-106.46M
Net Income	-116.98M
EBITDA	69.71M
EBIT	2.90M
Loss Per Share	-0.04

Balance Sheet

The company has 19.39 million in cash and 645.61 million in debt, giving a net cash position of -626.21 million or -0.21 per share.

Cash & Cash Equivalents	19.39M
Total Debt	645.61M
Net Cash	-626.21M
Net Cash Per Share	-0.21
Equity (Book Value)	1.02B
Book Value Per Share	0.33
Working Capital	-563.19M

Cash Flow

In the last 12 months, operating cash flow was 289.38 million and capital expenditures -36.26 million, giving a free cash flow of 253.12 million.

Operating Cash Flow	289.38M
Capital Expenditures	-36.26M
Free Cash Flow	253.12M
FCF Per Share	0.08

Margins

Gross margin is 3.40%, with operating and profit margins of 0.07% and -2.95%.

Gross Margin	3.40%
Operating Margin	0.07%
Pretax Margin	-2.70%
Profit Margin	-2.95%
EBITDA Margin	1.77%
EBIT Margin	0.07%
FCF Margin	6.42%

Dividends & Yields

BKK:BIOTEC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	n/a
Earnings Yield	-17.41%
FCF Yield	37.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BKK:BIOTEC has an Altman Z-Score of 1.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.43
Piotroski F-Score	4